Milliporesigma Brochures

  1. The Device Of Choice For Applications Requiring Higher Yield 10/16/2025

    High-flux membranes enable scalable filtration of biologics even under harsh conditions. Ideal for high-viscosity feeds, these cassettes support efficient processing and reliable cleanability.

  2. Regionalized Filter Supply Chain: Biopharma Supply, Reimagined 10/16/2025

    Discover a regionalized filtration network that delivers consistency, security, and sustainability for biopharma manufacturing—featuring ISO-certified sites, climate-neutral operations, and a broad filter portfolio.

  3. Higher Titers In Small-Cell Culture Systems And Bench-Scale Bioreactors 10/6/2025

    Accelerate your gene therapy development with a streamlined platform that simplifies vector production, reduces costs, and maintains high product quality from process design to clinical readiness.

  4. Achieve Higher Targeted Concentrations 9/30/2025

    High-concentration protein therapies offer patient and clinician benefits, but processing them introduces pressure-related challenges. Learn more about how pressure impacts final concentration outcomes.

  5. Innovation At Your Fingertips 9/8/2025

    Variability in cell culture media can impact product quality. Explore how CCM Fingerprinting quantifies key components in a single assay to help streamline release testing and media development.

  6. Understand Your Stability Programs 8/14/2025

    A stability program evaluates how pharmaceutical and biologic products maintain potency, purity, and quality over time, which ensures safety, effectiveness, and regulatory compliance.

  7. AAV Gene Therapy: Charting The Course Through Clinical Challenges 8/11/2025

    Clinical holds in AAV gene therapy often stem from CMC and quality issues. Learn about testing services that help developers navigate regulatory hurdles and accelerate therapeutic progress.

  8. A High-Purity Excipient Suitable For High-Risk Vaccine Applications 7/21/2025

    Examine an ultra-pure, sustainable alternative to shark-derived squalene. With ≥99% purity, it ensures safety, consistency, and ethical sourcing for innovation.

  9. An Alternative Suitable For High-Risk Applications 7/21/2025

    Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Explore more about its vital role in modern immunology innovation.

  10. AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone 6/17/2025

    Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.